Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Atsuko Matsuoka

Treatment of a Case of Severe Insulin Resistance Due to a PIK3R1 Mutation With a Sodium-Glucose Cotransporter-2 Inhibitor

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Usefulness of the Index Calculated as the Product of Levels of Fasting Plasma Glucose and Hemoglobin A1c for Insulinoma Screening

Endocrine Journal
EndocrinologyMetabolismDiabetes
2020English

Related publications

Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis

European Scientific Journal ESJ
2019English

Ertugliflozin: A Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes

Therapeutics and Clinical Risk Management
2018English

Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, With Dapagliflozin and Ipragliflozin

Pharmaceutics
Pharmaceutical Science
2020English

Protective Effects of Ipragliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, on a Non-Alcoholic Steatohepatitis Mouse Model

Yonago Acta Medica
Medicine
2019English

An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors

Journal of Clinical Medicine Research
2019English

The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Corrigendum to a Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2019English

Increased Grip Strength With Sodium-Glucose Cotransporter 2

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2016English

Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy